Try our Advanced Search for more refined results
Health - November, 2004
24 articles
- Supreme Court Won't Hear Patent Dispute Over Cox-2 Inhibitors
- Glaxo Urges Sweeping International Patent Reforms In Letter To Blair
- Indian Drug Makers Seek Ban On Patent Evergreening Under New Regime
- Canada's Generics Export Program Falters Amid Litigation Fears
- Pfizer Sues Chinese Agency Over Rejected Envacar Trademark
- Jury Rules For Inverness In Patent Suit Vs. Acon Labs
- Pfizer Withheld Crucial Data In Lipitor Patent Filing, Ranbaxy Claims
- Teamsters Sue AstraZeneca Over Nexium Claims
- U.S. Bill Would Protect Research Collaborations From Patent Challenges
- European Patent Office Invalidates Patent For Nitric Oxide
- Taiwanese Upstart Emerges As Threat To Biovail's Wellbutrin XL Patent
- China Could Become Hotbed For "Generic Viagra" Exports, Lobbyist Claims
- Australia Agrees To Tougher Copyright Laws To Gain Passage Of Free Trade Agreement
- Roche Sues Biosite Over Patents For Diagnostic Tests
- Applera Sues Gene Research Rivals On Same Day Patent Is Granted
- India Mulls Pre-Negotiation Of Prices For Patented Drugs
- Elan, Mayo Settle Patent Dispute Over Transgenic Mouse
- India's Leftist Parties Urge Government To Delay Patent Reform
- Biotech Upstart Sues Boston Scientific Over Patent, Trade Secrets
- Missouri Federal Court Limits First-Filed Rule in Trademark Case
- Judge Dismisses Biotech Suit Vs. Columbia University
- Florida Inventor Sues GE Over Surgical Device
- E.U. Mulls Compulsory Licensing System For Drugs
- Japan Policy Panel Stalls On Drug Patents